Correspondence 0001193125-24-035631 from Kura Oncology, Inc. (KURA) (CIK 0001422143) (KURA)
Kura Oncology, Inc. (KURA) (CIK 0001422143)
Date: Feb. 14, 2024 · CIK: 0001422143 · Accession: 0001193125-24-035631
AI Filing Summary & Sentiment
File numbers found in text: 333-276995
Letter
Kura Oncology, Inc.
12730 High Bluff Drive
Suite 400
San Diego, CA 92130
(858) 500-8800
February 14, 2024
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Daniel Crawford
Re: Kura Oncology, Inc.
Registration Statement on Form S-3
File No. 333-276995
Ladies and Gentlemen:
Kura Oncology, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective at 4:00 p.m. Eastern Time on Wednesday, February 14, 2024, or as soon thereafter as is practicable, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes Charles J. Bair of Cooley LLP and Wade W. Andrews of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Charles J. Bair at (858) 550-6142, or in his absence, Wade W. Andrews at (858) 550-6042.
Sincerely,
KURA
ONCOLOGY, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Kura Oncology, Inc. 12730 High Bluff Drive Suite 400 San Diego, CA 92130 (858) 500-8800 February 14, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Daniel Crawford Re: Kura Oncology, Inc. Registration Statement on Form S-3 File No. 333-276995 Ladies and Gentlemen: Kura Oncology, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective at 4:00 p.m. Eastern Time on Wednesday, February 14, 2024, or as soon thereafter as is practicable, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes Charles J. Bair of Cooley LLP and Wade W. Andrews of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with Charles J. Bair at (858) 550-6142, or in his absence, Wade W. Andrews at (858) 550-6042. Sincerely, KURA ONCOLOGY, INC. By: /s/ Troy E. Wilson, Ph.D., J.D. Troy E. Wilson, Ph.D., J.D. President and Chief Executive Officer cc: Charles J. Bair, Cooley LLP Wade W. Andrews, Cooley LLP